Hinge Health buys Cylinder for $105 million
Digital health platforms can no longer survive by treating only one pain point.
August 26, 2026
Follow us
latest articles
Discover the newest research about AI innovations in π½οΈ Gastroenterology.
AI groups early colon cancer recurrence risks
Unsupervised machine learning reveals that tumor shape, not just invasion depth, dictates whether early colorectal cancer will return after endoscopic removal.
August 22, 2026
Doctors adopted a specialized AI for bowel disease
A new clinical trial shows that doctors will actually use generative AI in daily practice, provided it is chained to strict medical guidelines rather than the open web.
July 31, 2026
AI extracts liver disease data from clinical text
A new study shows that off-the-shelf language models can reconstruct complex patient histories from messy clinical notes without manual human labeling.
June 23, 2026
AI matches pathologists in scoring ulcerative colitis
A new foundation model matches or beats human pathologists at grading ulcerative colitis biopsies, potentially solving the clinical trial replication crisis.
June 12, 2026
Good Hope Hospital Introduces Capsule Endoscopy Technology for Small Bowel Examination
Good Hope Hospital adopts capsule endoscopy technology for small bowel exams. This innovation enhances patient comfort and diagnostic accuracy. πΈπ
May 9, 2026
Classification of biliary strictures using real-time cholangioscopy artificial intelligence: the SMART-AI trial.
AI surpasses traditional methods in classifying biliary strictures: 87.8% accuracy vs. 67.4%. Significant implications for patient care! π€π
April 13, 2026
Artificial intelligence-driven gastrointestinal functional assessment: multimodal imaging, digital biomarkers, and real-time monitoring.
AI transforms GI health: multimodal imaging, digital biomarkers, and real-time monitoring enhance assessment and management. ππ€
April 13, 2026
Radiomics and artificial intelligence-based prediction of tumor response in digestive system neoplasm: a systematic review and meta-analysis.
Radiomics & AI enhance tumor response prediction in GI neoplasms. Key findings: ORs range from 8.12 to 11.62. ππ
March 26, 2026
Nearly 1,000 Participants Enrolled in LiveWell Liver Study Using NHS Data
Nearly 1,000 participants joined the LiveWell Liver Study in under a year, utilizing NHS data for research. ππ©Ί
March 23, 2026